Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Deticene

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,530Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Grants Priority Review for Opdivo Plus Chemo in Lymphoma
    FDA Grants Priority Review for Opdivo Plus Chemo in Lymphoma

    11 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-11/us-food-and-drug-administration-fda-grants-priority-review-to-bristol-myers-squibbs-application

    PHARMIWEB
    11 Dec 2025
    Share Share
    Seagen Eyes a Key Frontline Indication for Top-Seller Adcetris
    Seagen Eyes a Key Frontline Indication for Top-Seller Adcetris

    13 Dec 2022

    // Kate Goodwin BIOSPACE

    https://www.biospace.com/article/seagen-eyes-a-key-frontline-indication-for-adcetris/

    Kate Goodwin BIOSPACE
    13 Dec 2022
    Share Share
    Teva's troubled plant seen to create injectable drug shortages
    Teva's troubled plant seen to create injectable drug shortages

    24 May 2022

    // Joseph Keenan FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/tevas-halt-production-troubled-plant-seen-create-shortages-range-injectables

    Joseph Keenan FIERCEPHARMA
    24 May 2022
    Share Share
    ADCETRIS Combination Significantly Improves Overall Survival in Hodgkin Lymphoma
    ADCETRIS Combination Significantly Improves Overall Survival in Hodgkin Lymphoma

    03 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220203005330/en

    BUSINESSWIRE
    03 Feb 2022
    Share Share
    Seagen Announces Preliminary Results from Phase 2 Trial of ADCETRIS
    Seagen Announces Preliminary Results from Phase 2 Trial of ADCETRIS

    12 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211212005054/en

    BUSINESSWIRE
    12 Dec 2021
    Share Share
    Enforcement Report - Week of March 3, 2021
    Enforcement Report - Week of March 3, 2021

    03 Mar 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-3-2021-1614760051.pdf

    FDA
    03 Mar 2021
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.